#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4382069	Binding	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 100 nM incubated for 36 hrs by Western blot analysis	Homo sapiens	2	ALA4376901	cell-based format	Scientific Literature
2.	ALA4382070	Binding	Protac activity at CRBN/ABL in human K562 cells assessed as reduction in ABL protein levels at 100 nM incubated for 36 hrs by Western blot analysis	Homo sapiens	2	ALA4376901	cell-based format	Scientific Literature
3.	ALA4382071	Unassigned	Drug metabolism assessed as photoisomerization to cis-isomer after exposure to UV-C light and measured after 1 hr by UV-visible absorption spectra analysis		1	ALA4376901	assay format	Scientific Literature
4.	ALA4382072	Unassigned	Drug metabolism assessed as photoisomerization to trans-isomer after exposure to UV-C light and measured up to 120 mins by UV-visible absorption spectra analysis		1	ALA4376901	assay format	Scientific Literature
5.	ALA4382073	Unassigned	Drug metabolism assessed as photoisomerization to cis-isomer after exposure to white light light up to 240 mins by UV-visible absorption spectra analysis		1	ALA4376901	assay format	Scientific Literature
6.	ALA4382074	Physicochemical	Half life for spontaneous thermal relaxation under dark condition at 25 degC		1	ALA4376901	small-molecule physicochemical format	Scientific Literature
7.	ALA4382075	Physicochemical	Stability in presence of 20 mM of GSH reduced in DMSO/PBS buffer (1:1) solution incubated for 48 hrs		1	ALA4376901	small-molecule physicochemical format	Scientific Literature
8.	ALA4382076	Functional	Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
9.	ALA4382077	Functional	Cytotoxicity against human K562 cells assessed as inhibition of cell viability incubated for 48 hrs by Cell-titer-Glo luminescent cell viability assay	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
10.	ALA4382078	Functional	Cytotoxicity against human A549 cells assessed as inhibition of cell viability incubated for 48 hrs by Cell-titer-Glo luminescent cell viability assay	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
11.	ALA4382079	Functional	Cytotoxicity against human HCT116 cells assessed as inhibition of cell viability incubated for 48 hrs by Cell-titer-Glo luminescent cell viability assay	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
12.	ALA4382080	Functional	Cytotoxicity against human MCF7 cells assessed as inhibition of cell viability incubated for 48 hrs by Cell-titer-Glo luminescent cell viability assay	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
13.	ALA4382081	Binding	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with ABL inhibitor dasatinib followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
14.	ALA4382082	Binding	Protac activity at CRBN/ABL in human K562 cells assessed as reduction in ABL protein levels pre-treated with ABL inhibitor dasatinib followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
15.	ALA4382085	Binding	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with lenalidomide followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
16.	ALA4382086	Binding	Protac activity at CRBN/ABL in human K562 cells assessed as reduction in ABL protein levels pre-treated with lenalidomide followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
17.	ALA4382087	Binding	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with NEDD8-activating enzyme (NAE) inhibitor MLN4924 followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
18.	ALA4382088	Binding	Protac activity at CRBN/ABL in human K562 cells assessed as reduction in ABL protein levels pre-treated with NEDD8-activating enzyme (NAE) inhibitor MLN4924 followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
19.	ALA4382089	Binding	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels incubated for 36 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
20.	ALA4382090	Binding	Protac activity at CRBN/ABL in human K562 cells assessed as reduction in ABL protein levels incubated for 36 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature